What an evidence-linked drug-interaction warning should contain

A useful warning explains the risk in plain language, identifies urgency, cites available evidence and gives staff a safe next action.

Clinical responsibility: NgMedicare supports pharmacy teams. It does not diagnose, prescribe or replace pharmacist judgement.

Author: NgMedicare product teamPublished: 15 July 2026Updated: 15 July 2026Clinical review: product education only; not medical advice

BNF 85Current referenced edition

Nigeria EML2020 source included

Role controlledAuthorized pharmacy access

Audit recordedReviewable clinical activity

Name the practical risk

Translate technical mechanisms into clear consequences without exaggeration.

Not every interaction should stop dispensing. Severity must drive the action.

Record the source edition and relevant evidence so pharmacists can review it.

Prioritize actionable warnings and review override patterns rather than producing undifferentiated alerts.

Questions from pharmacy leaders

Should every interaction be denied?

No. The response should reflect documented severity and the pharmacist's patient-specific assessment.

For pharmacy and healthcare organizations

Tell us your city, organization type and number of locations. Do not include patient information.